S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
66,000% upside on tiny biotech? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Reasons Unity Software Is Ready to Rally 38%
66,000% upside on tiny biotech? (Ad)
3 Stocks That Really, Really Need the Defense Bill to Pass
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
The single greatest medical breakthrough of all time? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
Stock market today: World shares mixed after Wall Street retreat deepens
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
66,000% upside on tiny biotech? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Reasons Unity Software Is Ready to Rally 38%
66,000% upside on tiny biotech? (Ad)
3 Stocks That Really, Really Need the Defense Bill to Pass
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
The single greatest medical breakthrough of all time? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
Stock market today: World shares mixed after Wall Street retreat deepens
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
66,000% upside on tiny biotech? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Reasons Unity Software Is Ready to Rally 38%
66,000% upside on tiny biotech? (Ad)
3 Stocks That Really, Really Need the Defense Bill to Pass
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
The single greatest medical breakthrough of all time? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
Stock market today: World shares mixed after Wall Street retreat deepens
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
66,000% upside on tiny biotech? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Reasons Unity Software Is Ready to Rally 38%
66,000% upside on tiny biotech? (Ad)
3 Stocks That Really, Really Need the Defense Bill to Pass
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
The single greatest medical breakthrough of all time? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
Stock market today: World shares mixed after Wall Street retreat deepens
NYSE:CHE

Chemed (CHE) Stock Forecast, Price & News

$513.90
-0.57 (-0.11%)
(As of 09/26/2023 ET)
Compare
Today's Range
$507.52
$515.45
50-Day Range
$499.76
$568.61
52-Week Range
$430.16
$574.66
Volume
56,874 shs
Average Volume
70,854 shs
Market Capitalization
$7.75 billion
P/E Ratio
34.26
Dividend Yield
0.31%
Price Target
$593.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
15.4% Upside
$593.00 Price Target
Short Interest
Healthy
3.48% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
0.73mentions of Chemed in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$2.07 M Sold Last Quarter
Proj. Earnings Growth
16.74%
From $19.12 to $22.32 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.05 out of 5 stars

Medical Sector

29th out of 963 stocks

Home Health Care Services Industry

2nd out of 7 stocks


CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

CHE Price History

CHE Stock News Headlines

Zacks Research Comments on Chemed Co.'s Q3 2023 Earnings (NYSE:CHE)
New Breakthrough "Living Software" Has Been…
New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>
Chemed (CHE) Faces Macroeconomic Woes, Tough Competition
Chemed - Showcasing Why It's So Reliable
New Breakthrough "Living Software" Has Been…
New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>
Chemed (CHE) Declares $0.40 Dividend
Chemed Corp. Raises Quarterly Dividend by 5.3% >CHE
Chemed: Q2 Earnings Snapshot
Chemed Corp. Q2 Income Retreats, misses estimates
Chemed (CHE) Q2 Earnings and Revenues Lag Estimates
Chemed Reports Second-Quarter 2023 Results
Here's what Wall Street expects from Chemed's earnings report
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
7/26/2023
Ex-Dividend for 9/5 Dividend
8/11/2023
Dividend Payable
9/05/2023
Today
9/27/2023
Next Earnings (Estimated)
10/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,167
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$593.00
High Stock Price Forecast
$610.00
Low Stock Price Forecast
$576.00
Forecasted Upside/Downside
+15.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$249.62 million
Pretax Margin
13.73%

Debt

Sales & Book Value

Annual Sales
$2.19 billion
Cash Flow
$24.15 per share
Book Value
$53.71 per share

Miscellaneous

Free Float
14,504,000
Market Cap
$7.75 billion
Optionable
Optionable
Beta
0.53

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Kevin J. McNamaraMr. Kevin J. McNamara (Age 69)
    CEO, Pres & Director
    Comp: $5.66M
  • Mr. David P. Williams (Age 62)
    Exec. VP & CFO
    Comp: $2.63M
  • Mr. Michael D. Witzeman CPA (Age 52)
    MBA, VP & Controller
    Comp: $985.01k
  • Mr. Spencer S. LeeMr. Spencer S. Lee (Age 67)
    Exec. VP
    Comp: $1.86M
  • Mr. Thomas C. Hutton (Age 72)
    VP & Director
  • Mr. Nicholas Michael WestfallMr. Nicholas Michael Westfall (Age 44)
    Exec. VP
    Comp: $2.05M
  • Ms. Lisa A. Reinhard
    VP, Chief Admin. Officer & Sec.
  • Sherri Warner
    Director of Investor Relations
  • Mr. Brian C. Judkins (Age 42)
    VP, Sec. & Chief Legal Officer













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 analysts have issued twelve-month target prices for Chemed's stock. Their CHE share price forecasts range from $576.00 to $610.00. On average, they expect the company's share price to reach $593.00 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2023?

Chemed's stock was trading at $510.43 at the beginning of 2023. Since then, CHE stock has increased by 0.7% and is now trading at $513.8950.
View the best growth stocks for 2023 here
.

Are investors shorting Chemed?

Chemed saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 511,700 shares, a decline of 21.0% from the August 15th total of 648,000 shares. Based on an average daily volume of 71,900 shares, the days-to-cover ratio is currently 7.1 days. Currently, 3.5% of the shares of the stock are sold short.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its earnings results on Wednesday, July, 26th. The company reported $4.71 earnings per share for the quarter, missing the consensus estimate of $5.09 by $0.38. The firm earned $553.80 million during the quarter, compared to analyst estimates of $562.54 million. Chemed had a trailing twelve-month return on equity of 34.65% and a net margin of 10.36%. The business's revenue was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business earned $4.84 EPS.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, August 4th. Investors of record on Monday, August 14th will be given a dividend of $0.40 per share on Tuesday, September 5th. This represents a $1.60 annualized dividend and a yield of 0.31%. The ex-dividend date of this dividend is Friday, August 11th. This is an increase from the stock's previous quarterly dividend of $0.38.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.31%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 10.67%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.17% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY 2023 earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $19.90-$20.10 for the period, compared to the consensus estimate of $20.92. The company issued revenue guidance of -.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.39%), William Blair Investment Management LLC (3.72%), Kayne Anderson Rudnick Investment Management LLC (3.43%), Durable Capital Partners LP (3.03%), State Street Corp (2.94%) and Impax Asset Management Group plc (1.98%). Insiders that own company stock include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends
.

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $513.90.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $7.75 billion and generates $2.19 billion in revenue each year. The company earns $249.62 million in net income (profit) each year or $15.00 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,167 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -